The Use of B-type Natriuretic Peptide (BNP) to Predict Closure of a Patent Ductus Arteriosus (PDA) in Premature Infants
NACompletedINTERVENTIONAL
Enrollment
60
Participants
Timeline
Start Date
April 30, 2004
Study Completion Date
March 31, 2007
Conditions
Indomethacin TherapyPatent Ductus Arteriosus
Interventions
PROCEDURE
Withhold standard INDO dose if BNP < 100 pg/ml
All Listed Sponsors
lead
University of Virginia
OTHER
NCT00500305 - The Use of B-type Natriuretic Peptide (BNP) to Predict Closure of a Patent Ductus Arteriosus (PDA) in Premature Infants | Biotech Hunter | Biotech Hunter